The study of immunity in children with multiple papillomas
https://doi.org/10.25789/YMJ.2018.63.35
Abstract
In order to study the features of immunity in children with multiple papillomas and the effectiveness of therapy with groprinosin and lycopid drugs, a group of children with multiple papillomas and a group of healthy children, comparable in age, were examined. All children showed a positive PCR for HPV, a histological examination of the papillomas, as well as an examination of the immune status were done. It was revealed that in children with papillomas the content of IgA, CD19 + and CD16 + lymphocytes was reduced. The therapy with groprinosin and lycopid medications leads to normalization of the lowered immune status indicators, as well as to the cessation of the appearance of new papillomas in children.
About the Authors
O. N. Ivanova
NEFU
Russian Federation
Russian Federation
Ivanova Olga Nikolaevna -doctor of medical sciences, Professor of Pediatrics and pediatric surgery Department
E. F. Argunova
MI NEFU
Russian Federation
Russian Federation
Argunova Elena Filippovna – candidate of medical Sciences, associate Professor of Pediatrics and pediatric surgery
T. G. Dmitrieva
NEFU
Russian Federation
Russian Federation
Dmitrieva Tatyana Gennadievna - doctor of medical sciences, Professor of Pediatrics and pediatric surgery Department
Ya. A. Munchalova
Medical Institute of NEFU
Russian Federation
Russian Federation
Munkhalova Yana Afanasievna - Candidate of Medical Sciences, Head of the Department of Pediatrics and Pediatric Surgery
V. B. Egorova
Medical Institute of NEFU
Russian Federation
Russian Federation
Egorova Vera Borisovna - Candidate of Medical Sciences, Associate Professor of the Department of Pediatrics and Pediatric Surgery
S. N. Alekseeva
Medical Institute of NEFU
Russian Federation
Russian Federation
Alekseeva Sargylana Nikolaevna - Candidate of Medical Sciences, Associate Professor of the Department of Pediatrics and Pediatric Surgery
References
1. Kostava M.N. Possibilities of therapy of papillomavirus infection / M.N. Kostava, V.N. Prilepskaya // Rus. med. journal. - 2009. - 17 (1). - P. 9-16.
2. Mynbayev O.A. Epidemiology, molecular biol ogy, pathophysiology, principles of immunothe rapy of papillomavirus infection / O.A. Mynbayev, M. Yu. Eliseeva, J. Doorbar, I.B. Manukhin // Problems of Gynecology, Obstetrics and Perinatology. - 2009. - 8 (3). - P.69-79.
3. Nesterova I.V. Strategy and tactics of immunotherapy of secondary immunodeficiencies with an infectious syndrome / I.V. Nesterova // Herald of the MEDSI. - 2009. - 3. - P. 24-32.
4. Prilepskaya V.N. Papillomavirus infection: diagnosis, treatment and prevention/ V.N. Prilepskaya, S.I. Rogovskaya, N.I. Kondrikov, G.T. Sukhikh. – M.: MEDpress-inform, 2007.
5. Determinants of cervical human papillomavirus infection: Differences between high- and lowoncogenic risk types / Chan P. K., Chang A. R., Cheung J. L. [et al.] // J Infect Dis. - 2002. - 185. - P.28-35.
Review
For citations:
Ivanova O.N., Argunova E.F., Dmitrieva T.G., Munchalova Ya.A., Egorova V.B., Alekseeva S.N. The study of immunity in children with multiple papillomas. Yakut Medical Journal. 2018;(3):107-109. https://doi.org/10.25789/YMJ.2018.63.35
Views:
3
Email this article 